Home › Funds › North Growth Management Ltd. › CROX
North Growth Management Ltd. position in CROX
CROCS INC · Consumer Discretionary
North Growth Management Ltd. reported holding 125,000 shares of CROX (CROCS INC) in its Q3 2026 13F filing — a position valued at US$14.7M, representing 1.98% of its reported portfolio and ranking #21 among its reported holdings. North Growth Management Ltd. has disclosed CROX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How North Growth Management Ltd.'s CROX position evolved
North Growth Management Ltd. first disclosed a stake in CROX in Q3 2023 at 69,000 shares (US$6.1M). The position peaked in Q2 2026 at 124,000 shares, worth US$14.9M. Across 13 filings, North Growth Management Ltd. increased the stake 6 time(s), trimmed it 1 time(s) and left it unchanged 5 time(s). The most recent filing (Q3 2026) shows 125,000 shares valued at US$14.7M — an increase of 1,000 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 69.00K | $6.08M | New |
| Q4 2023 | 69.00K | $6.43M | Hold |
| Q1 2024 | 86.00K | $12.40M | Add |
| Q2 2024 | 86.00K | $12.61M | Hold |
| Q3 2024 | 87.00K | $12.54M | Add |
| Q4 2024 | 85.00K | $9.32M | Reduce |
| Q1 2025 | 85.00K | $9.07M | Hold |
| Q2 2025 | 85.00K | $8.65M | Hold |
| Q3 2025 | 85.00K | $7.09M | Hold |
| Q4 2025 | 103.00K | $8.84M | Add |
| Q1 2026 | 123.00K | $10.19M | Add |
| Q2 2026 | 124.00K | $14.92M | Add |
| Q3 2026 | 125.00K | $14.72M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About CROX and 13F data
CROX (CROCS INC) is a Consumer Discretionary company. 28 other funds we track also report a position in CROX — the largest reported positions include Himalaya Capital (US$107.0M), No Street GP LP (US$98.9M), Patient Capital Management, LLC (US$85.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding CROX
- Himalaya Capital 887.09K sh · $107.02M · Q2 2026
- No Street GP LP 820.00K sh · $98.92M · Q2 2026
- Patient Capital Management, LLC 730.95K sh · $85.75M · Q3 2026
- Smead Capital Management, Inc. 709.82K sh · $83.27M · Q3 2026
- DME Capital Management, LP 669.14K sh · $80.73M · Q2 2026
- WIT Partners Advisory Pte. Ltd. 632.81K sh · $74.24M · Q3 2026
- Evercore Wealth Management, LLC 594.86K sh · $71.76M · Q2 2026
- Punch Card Management L.P. 577.17K sh · $69.63M · Q2 2026
More on North Growth Management Ltd.
FAQ
How long has North Growth Management Ltd. held CROX?
North Growth Management Ltd. has disclosed CROX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is North Growth Management Ltd.'s current position in CROX?
As of Q3 2026, North Growth Management Ltd. holds 125.00K shares of CROX (CROCS INC), valued at $14.72M, representing 1.98% of its reported portfolio and ranking #21.
Has North Growth Management Ltd. been buying or selling CROX?
In the latest 13F filing (Q3 2026), North Growth Management Ltd. increased its position in CROX. The position peaked in Q2 2026 at 124.00K shares.
Which other funds hold CROX?
Other major institutional holders of CROX include Himalaya Capital, No Street GP LP, Patient Capital Management, LLC, among 28 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.